Fresenius Medical Care AG (NYSE:FMS – Get Free Report)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $24.19, but opened at $23.35. Fresenius Medical Care shares last traded at $23.21, with a volume of 31,033 shares changing hands.
Analysts Set New Price Targets
A number of equities research analysts have commented on FMS shares. Truist Financial raised their price objective on Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research note on Monday, December 2nd. Finally, StockNews.com raised Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th.
Get Our Latest Analysis on FMS
Fresenius Medical Care Stock Up 3.7 %
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of FMS. Smartleaf Asset Management LLC lifted its holdings in Fresenius Medical Care by 192.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock worth $28,000 after acquiring an additional 806 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in Fresenius Medical Care during the third quarter worth $38,000. Russell Investments Group Ltd. lifted its holdings in Fresenius Medical Care by 234.1% during the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company’s stock worth $71,000 after acquiring an additional 2,208 shares during the period. Jones Financial Companies Lllp lifted its holdings in Fresenius Medical Care by 80.5% during the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company’s stock worth $102,000 after acquiring an additional 2,012 shares during the period. Finally, Venturi Wealth Management LLC lifted its holdings in Fresenius Medical Care by 8.4% during the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company’s stock worth $129,000 after acquiring an additional 441 shares during the period. Institutional investors own 8.37% of the company’s stock.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- 3 Best Fintech Stocks for a Portfolio Boost
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Top Stocks Investing in 5G Technology
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- How to Capture the Benefits of Dividend Increases
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.